Oppenheimer raised the firm’s price target on Corteva (CTVA) to $76 from $75 and keeps an Outperform rating on the shares. The firm remains constructive on shares of Corteva following a strong Q3 reminding investors why it has historically garnered a quality premium. Despite continued end-market challenges, the company delivered another beat-and-raise on strong volumes, execution against controllables, and comparatively dampened price pressures, Oppenheimer adds.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTVA:
- Corteva’s Strategic Adjustments and Strong Crop Protection Performance Drive Buy Rating
- Corteva’s Strong Q3 Performance Boosts 2025 Outlook
- Corteva’s Earnings Call: Strong Growth and Raised Guidance
- Corteva reports Q3 adjusted EPS (23c), consensus (47c)
- Corteva raises FY25 operating EPS view to $3.25-$3.35 from $3.00-$3.20